Cargando…
Regression Rates Following the Treatment of Aggressive Posterior Retinopathy of Prematurity with Bevacizumab Versus Laser: 8-Year Retrospective Analysis
BACKGROUND: Retinopathy is a serious complication related to prematurity and a leading cause of childhood blindness. The aggressive posterior form of retinopathy of prematurity (APROP) has a worse anatomical and functional outcome following laser therapy, as compared with the classic form of the dis...
Autores principales: | Nicoară, Simona D., Ştefănuţ, Anne C., Nascutzy, Constanta, Zaharie, Gabriela C., Toader, Laura E., Drugan, Tudor C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4918525/ https://www.ncbi.nlm.nih.gov/pubmed/27062023 http://dx.doi.org/10.12659/MSM.897095 |
Ejemplares similares
-
Outcomes and Prognostic Factors of Intravitreal Bevacizumab Monotherapy in Zone I Stage 3+ and Aggressive Posterior Retinopathy of Prematurity
por: Nicoară, Simona Delia, et al.
Publicado: (2015) -
Bevacizumab or laser for aggressive posterior retinopathy of prematurity
por: Blair, Michael, et al.
Publicado: (2018) -
Comment on “bevacizumab or laser for aggressive posterior retinopathy of prematurity”
por: Samanta, Ramanuj
Publicado: (2019) -
Reply to comment on: “Advantages of bevacizumab for aggressive posterior retinopathy of prematurity”
por: Schechet, Sidney A., et al.
Publicado: (2019) -
Favorable outcomes of adequate laser photocoagulation and salvage bevacizumab treatment for aggressive posterior retinopathy of prematurity
por: Fukushima, Yoko, et al.
Publicado: (2018)